ISEE - IVERIC bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
230.32M
Enterprise Value 3
84.8M
Trailing P/E
3.54
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
2.52
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.46

Trading Information

Stock Price History

Beta (3Y Monthly) 1.55
52-Week Change 3255.10%
S&P500 52-Week Change 318.93%
52 Week High 35.42
52 Week Low 30.91
50-Day Moving Average 33.14
200-Day Moving Average 31.68

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 31.33M
Shares Outstanding 541.61M
Float 26.5M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Nov 15, 2019) 41.5M
Short Ratio (Nov 15, 2019) 40.4
Short % of Float (Nov 15, 2019) 44.14%
Short % of Shares Outstanding (Nov 15, 2019) 43.60%
Shares Short (prior month Oct 15, 2019) 4480.82k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.40%
Return on Equity (ttm)132.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-34.84M
EBITDA -58.16M
Net Income Avi to Common (ttm)62.73M
Diluted EPS (ttm)1.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)94.85M
Total Cash Per Share (mrq)2.28
Total Debt (mrq)745k
Total Debt/Equity (mrq)0.83
Current Ratio (mrq)10.36
Book Value Per Share (mrq)2.15

Cash Flow Statement

Operating Cash Flow (ttm)-46.66M
Levered Free Cash Flow (ttm)-28.74M